Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 70.3"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 26.1;monocytes: 7.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	26.5	10.5	5.2	7.4	12.2	32.2	70.3	8.5	10.3	7.6	10.2	10.5	5.9	7.4	4.6	4.0	22.7	3.7	10.4	9.8	7.4	4.5	10.1	18.4	14.1	8.7	18.5	4.6	4.2	12.8	9.1	8.6	20.2	14.9	5.8	6.7	4.4	21.1	7.4	10.4	24.8	15.1	8.1	19.0	7.0	8.9	8.1	12.5	3.3	13.2	9.9	6.7	11.2	16.0	1.7	3.6	26.1	7.6	0.9	2.4	2.5	8.5	3.0	3.6	3.8	15.2	5.8	7.5	34.9	13.9	9.6	7.2	4.7	3.0	7.1	4.8	10.9	8.5	2.8	5.7	8.5	9.8	25.8	5.5	18.2	11.6	3.2	7.6	4.1	5.9	6.4	29.5	16.1	13.8	8.4	16.0	4.8	10.8	5.4	21.3	4.6	2.9	2.9	9.7	6.8	9.8	1.3	10.4	4.1	12.4	17.0	4.4	6.0	15.3	8.3	3.6	4.0	8.9	3.5	8.8	8.5	6.7	15.7	15.1	4.9	13.6	3.4	9.0	7.5	6.6	26.1	7.6	4.4	1.2	3.7	1.0	1.7	0.9	1.4	3.6	1.2	0.8	1.3	21.0	0.9	2.7	0.9	2.4	2.5	5.2	12.2	8.5	10.3	7.4	4.5	18.5	4.6	14.9	12.5	23.8	43.8	8.5	23.5	35.4	11.3	9.7	15.3	17.4	25.0	26.2	25.5	13.3	28.2	49.4	13.5	16.9	64.4	23.3	53.5	21.2	16.2	21.6	16.1	11.3	16.6	3.2	34.9	14.7	26.6	12.9	4.9	30.4	6.8	16.2	17.1	12.4	61.4	24.6	5.3	31.4	14.7	0.0	26.8	35.6	43.9	35.8	171.7	15.8	18.2	41.1
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.4	13.5	13.4	11.0	10.6	13.2	9.1	13.2	12.9	21.2	21.2	10.5	9.6	14.0	11.8	12.6	20.0	9.3	18.7	15.4	22.9	16.5	16.6	13.0	6.4	10.4	15.8	9.0	7.0	14.7	13.6	18.6	18.2	9.9	16.2	16.1	19.3	20.0	10.2	12.5	24.3	4.1	14.2	9.6	15.2	15.7	2.3	41.9	13.6	10.6	11.7	16.1	13.7	16.6	13.6	14.1	8.9	9.9	9.1	9.8	7.7	13.1	19.0	15.2	15.0	6.7	16.2	4.2	27.0	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0	0.0	5.9	3.7	5.1	2.7	10.7	16.8	5.1	6.7	5.7	12.2	7.9	13.4	8.3	6.3	10.0	5.8	2.0	0.0	6.1	6.7	5.4	2.6	8.1	4.5	6.1	14.3	0.0	3.1	4.7	8.5	6.4	4.7	6.8	18.0	2.9	9.8	4.6	0.0	9.9	6.1	16.4	0.0	6.2	4.6	4.9	2.4	7.7	11.4	5.6	2.7
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.3	23.8	12.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	11.6	33.7	9.5	3.3	29.1	9.6	0.0	0.0	22.5	0.0	0.0	29.0	0.0	0.0	27.3	13.3	12.4	0.0	12.6	29.0	8.2	23.0	17.3	17.7	29.2	7.3	0.0	6.3	0.0	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	14.6	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.6	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4	14.9	18.1	19.4	9.5	8.0	26.4	3.1	12.7	12.0	7.9	34.9	11.8	28.8	5.0	16.4	52.8	13.5	30.7	0.0	12.4	25.8	14.4	11.5	12.7	27.1	22.0	30.2	28.3	18.4	17.4	64.8	12.4	17.4	8.5	5.4	24.1	34.1	13.6	21.0	20.1	22.3	17.0	0.0	20.8	45.5	20.6	3.1	12.8	12.1	20.4	10.5
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 930.5;Paneth cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.7	20.8	2.4	11.5	17.9	5.6	10.5	9.8	7.8	6.7	5.1	23.6	29.2	4.9	22.1	5.6	10.9	40.1	3.5	6.1	0.7	50.5	15.9	7.2	8.6	5.1	12.3	7.5	17.6	5.3	8.5	5.7	3.0	5.8	3.5	6.6	8.7	0.8	2.8	26.6	0.5	23.5	6.3	27.2	37.8	11.1	8.9	26.9	7.9	9.3	5.5	8.9	12.7	13.4	16.1	2.0	8.5	29.8	6.8	8.9	9.2	2.9	6.2	1.2	0.1	3.1	0.1	16.3	8.9	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9	14.9	59.7	17.6	50.1	40.2	2.1	34.7	68.8	10.7	18.2	69.8	0.0	6.7	46.4	135.1	138.9	26.4	930.5	0.0	193.7	28.9	36.3	80.5	13.8	203.0	114.8	38.1	34.3	22.1	50.6	271.0	24.7	62.8	129.9	36.9	126.5	13.3	140.9	350.7	19.1	33.5	3.6	45.3	29.6	1.1	36.6	71.0	5.7	20.3	115.8	138.0
AGPAT3	LPAAT-gamma	ENSG00000160216	"1-acylglycerol-3-phosphate O-acyltransferase 3"	Q9NRZ7	21	43865186-43986536	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.1"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 172.8;Early spermatids: 230.1;Late spermatids: 164.7;Rod photoreceptor cells: 181.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.36e-2)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.50e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.50e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.60e-2)"	12.0	10.2	21.5	11.1	23.0	5.8	12.7	14.6	22.7	6.4	20.1	18.9	8.5	27.4	5.1	10.4	13.4	8.1	8.6	11.6	19.9	15.1	33.8	30.2	9.9	9.0	21.7	11.4	5.4	12.7	17.1	7.3	7.6	13.6	7.9	7.6	10.6	24.0	8.0	59.1	10.2	34.6	5.8	25.2	10.2	11.1	11.7	11.4	7.2	14.1	15.0	7.0	9.8	6.6	1.3	4.5	2.4	10.6	0.7	3.5	2.0	26.9	15.4	3.8	10.5	7.8	8.6	3.0	12.5	15.7	15.9	9.8	15.1	19.7	9.1	9.5	14.8	14.9	10.5	6.6	13.8	4.6	43.5	17.6	4.0	9.5	20.2	13.6	14.7	9.1	10.2	11.9	14.0	5.9	14.9	11.9	3.1	22.5	15.1	5.7	11.6	0.1	9.1	1.8	10.7	10.9	15.1	4.4	24.6	12.6	26.6	13.3	9.7	15.2	17.4	11.6	1.6	12.0	16.0	17.6	10.1	0.1	15.1	12.7	12.1	18.0	5.7	13.1	29.4	9.1	0.0	4.1	2.4	1.5	8.9	1.5	1.3	2.1	2.2	4.5	1.2	1.7	1.9	1.0	0.7	10.6	1.1	3.5	2.0	21.5	23.0	14.6	22.7	19.9	15.1	21.7	11.4	13.6	11.4	11.9	23.1	7.5	7.5	7.1	36.1	31.3	20.4	32.1	22.7	24.4	172.8	13.2	8.3	23.9	230.1	11.7	47.3	0.0	25.5	0.7	8.9	14.4	4.7	59.5	16.9	62.0	13.3	15.4	24.3	164.7	7.2	22.0	1.7	27.9	21.9	27.1	23.5	20.1	5.3	42.8	181.7	6.5	7.8	9.0	2.1	9.7	10.1	9.2	19.3	12.2
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 51.8;Late spermatids: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	9.2	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	7.1	4.6	2.3	7.3	6.8	1.8	0.0	1.0	1.6	4.7	0.0	7.5	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	8.1	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8	3.0	5.6	5.2	4.6	2.9	1.0	4.0	2.5	10.7	5.7	5.2	0.0	16.0	0.0	4.3	51.8	12.2	0.0	0.0	7.0	10.7	11.3	0.8	10.5	0.4	16.7	0.0	1.7	9.8	7.6	44.8	5.5	15.4	3.3	11.8	0.0	4.0	5.9	0.0	8.1	0.3	0.9	19.4	6.2	3.6	2.9	2.3	18.5	7.4	0.0	3.2
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708357-6759666	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.9	12.5	20.0	8.5	20.7	5.1	9.8	10.0	21.2	6.0	12.2	16.5	6.8	9.3	9.3	19.1	8.4	9.7	5.9	4.0	19.3	16.9	14.2	14.3	5.1	16.8	18.7	9.5	6.4	16.2	11.4	18.5	16.3	14.2	11.0	12.3	3.3	5.4	16.0	10.2	5.1	8.4	8.6	30.6	8.6	11.0	30.8	12.7	14.3	7.3	6.8	10.4	7.3	5.7	11.0	8.4	3.0	4.8	5.3	3.9	2.9	9.4	7.6	11.9	7.0	3.1	5.1	10.6	5.0	5.2	7.5	7.3	4.7	7.5	20.7	3.3	3.3	10.5	11.2	9.1	10.1	13.2	4.5	6.2	25.4	5.9	10.6	7.9	10.6	11.1	6.8	8.6	7.3	9.8	6.9	13.1	8.7	18.7	11.1	12.3	6.1	19.2	13.1	20.8	12.7	5.9	13.9	14.3	8.1	6.8	13.3	24.4	12.8	4.8	8.8	9.5	7.3	4.0	14.0	5.4	12.3	5.8	4.7	13.9	4.2	12.8	11.3	7.2	12.8	14.6	3.0	4.1	2.6	1.9	4.8	3.9	8.7	3.0	3.3	2.7	11.0	2.3	2.7	0.4	5.3	4.2	8.4	2.7	2.9	20.0	20.7	10.0	14.6	19.3	16.9	18.7	9.5	14.2	12.7	3.0	4.1	16.6	10.5	8.0	7.7	5.3	12.7	10.7	7.9	7.0	2.0	7.7	3.3	8.4	29.8	15.8	11.4	0.0	8.5	10.7	5.7	13.4	17.4	29.2	11.0	6.4	21.2	8.6	14.0	22.9	14.7	6.4	6.8	1.0	7.9	37.9	8.0	8.6	14.5	17.4	8.8	6.5	13.2	20.9	8.6	9.2	15.4	4.4	20.0	10.6
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Group enriched"	"Detected in some"	6	"Enterocytes: 45.5;Paneth cells: 17.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.7"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	2.0	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.7	2.3	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.6	0.0	1.1	1.1	0.5	0.0	0.2	53.1	0.0	41.5	0.1	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	12.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	26.4	0.3	0.0	0.0	0.1	14.8	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7	3.0	88.5	0.5	0.5	0.1	2.6	2.0	0.0	1.4	10.3	0.0	0.0	0.0	6.6	0.0	1.2	7.1	0.0	23.3	0.0	0.3	0.3	1.5	7.0	25.3	0.1	1.6	0.0	25.8	1.0	4.4	0.3	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	44.8	28.1	0.0	1.0	0.3	13.6	0.4	1.3	0.0	0.0	0.3
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	19	"Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 88.1;SiHa: 24.3"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.3	8.6	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.0
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.4	21.4	0.0	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0
CEPT1		ENSG00000134255	"Choline/ethanolamine phosphotransferase 1"	Q9Y6K0	1	111139627-111185102	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.20e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.27e-2)"	22.4	22.9	16.0	22.2	19.5	5.6	20.1	20.7	19.8	14.9	13.7	22.2	17.5	19.0	18.3	19.1	21.3	16.6	15.3	12.2	17.9	16.0	22.6	39.4	16.5	31.7	22.9	15.1	22.9	17.8	19.6	25.5	22.5	18.2	13.9	18.1	16.9	19.2	12.0	11.2	17.8	20.2	16.3	23.3	34.5	17.5	12.5	21.3	22.3	19.4	11.5	24.7	19.5	17.8	14.6	9.0	4.2	19.1	5.3	9.0	5.5	14.0	5.3	6.3	6.1	25.0	12.3	15.3	15.6	8.9	7.3	8.8	4.6	16.0	16.8	17.3	8.0	9.3	17.4	9.1	12.2	10.5	12.4	14.1	7.3	9.5	10.2	16.7	17.1	10.5	10.0	23.5	5.3	25.5	13.9	9.6	17.5	15.7	11.0	9.5	10.2	17.5	16.9	9.7	22.6	10.9	9.5	20.0	13.6	11.9	8.9	8.3	4.4	14.4	22.0	16.6	12.8	11.7	18.7	8.4	11.9	7.5	25.7	10.4	10.1	10.9	13.1	16.0	15.4	22.5	3.2	7.6	4.2	6.4	13.6	8.4	14.5	7.2	6.7	9.0	14.6	8.4	9.0	1.9	5.3	19.1	7.0	6.2	5.5	16.0	19.5	20.7	19.8	17.9	16.0	22.9	15.1	18.2	21.3	32.8	12.2	37.9	14.6	11.6	26.0	3.6	20.4	21.4	14.8	34.9	33.4	24.6	5.0	11.7	1.7	9.7	16.0	0.0	7.1	16.3	11.4	13.2	18.5	29.7	25.2	27.0	9.8	22.7	40.9	2.2	13.6	19.4	15.1	9.0	13.6	9.4	8.5	14.7	15.9	12.0	20.7	12.9	7.2	12.0	13.2	13.4	15.9	20.0	13.3	12.4
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742040-108763054	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.5;liver: 111.0"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Approved		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	1.2	1.9	50.8	1.3	51.3	1.2	1.3	7.9	53.5	1.3	1.2	13.4	0.0	1.3	1.4	1.2	1.3	1.2	1.4	3.2	37.5	20.1	6.2	111.0	1.2	1.2	26.0	28.7	1.3	1.2	1.4	0.1	1.2	15.7	1.2	1.2	0.5	19.9	1.3	1.6	1.2	1.2	1.2	7.3	1.6	10.4	1.5	18.7	0.0	1.9	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.1	11.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	2.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	51.3	7.9	24.9	37.5	20.1	26.0	28.7	15.7	18.7	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.6	1.0	1.3	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 165.5;Horizontal cells: 42.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 76.6;Hep G2: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.8	2.1	2.9	3.8	76.6	2.8	3.8	2.7	3.1	1.9	1.5	5.0	1.7	2.0	1.5	1.9	1.8	3.6	4.6	2.3	3.7	1.4	2.4	1.8	2.3	20.6	2.3	3.2	1.0	13.4	3.9	3.5	7.1	15.0	1.7	2.8	2.3	1.8	2.2	1.6	2.7	2.5	2.4	1.6	3.0	2.7	7.6	1.4	1.3	1.9	1.2	3.6	3.7	1.8	4.2	2.8	1.8	1.1	1.3	2.3	1.4	2.8	4.2	1.8	2.0	4.2	2.6	2.8	1.7	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2	8.9	19.0	7.8	0.6	0.3	5.8	15.7	17.8	5.3	5.7	5.2	9.8	4.6	1.7	2.5	0.4	4.5	1.7	0.0	2.8	2.1	2.5	1.2	2.3	165.5	2.5	42.9	1.2	5.5	8.9	0.4	4.9	2.1	1.7	0.0	3.8	6.0	2.6	2.9	11.3	2.7	8.9	6.5	1.9	2.9	3.2	0.1	1.6	3.2	4.5	0.5
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0"	"Low region specificity"	"Detected in single"							HPA036841	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	4.3	1.1	1.5	1.9	3.1	1.5	3.6	0.2	1.6	0.8	1.0			0.0	1.1	5.1	0.9	1.0	2.2	3.9	1.1	0.7	0.5	0.5	1.3	3.2	1.2		0.9	1.1	0.0	0.2	2.0		0.6	1.5		1.8	4.9	1.4	0.5	1.3	2.4	2.3	4.4	3.0	7.3			1.2		2.6	2.6	0.8	4.3	1.1	0.5	2.5	0.2	3.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.0	17.5	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	2.6	1.9	2.8	4.3	1.3	2.0	1.1	4.1	0.8	3.0	0.0	0.2	2.5	0.0	1.3	1.5											0.0	0.6	2.4	0.6	0.9	0.7	1.6	2.5	0.0	0.0	1.8	0.0	0.1	1.7	1.7	1.5	2.9	0.4	0.0	1.6	0.2	2.2	0.5	1.1	0.0	2.2	7.9	0.0	6.7	1.0	4.3	0.6	1.0	1.7	1.0	0.7	0.9	0.8	0.6	0.0	0.0	0.2	97.0	18.3	27.9	16.8	0.1	0.1	0.7	1.3	1.6
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	9.8	9.7	0.0	0.1	0.5	1.2	0.2	0.7	1.4	0.2	0.2	0.7	51.6	0.0	1.1	1.8	39.2	2.2	4.6	0.9	0.1	0.6	2.2	0.0	3.1	9.5	1.4	2.8	19.0	0.6	0.0	0.3	1.1	3.8	4.8	2.7	7.9	7.8	0.2	1.0	0.7	0.7	0.2	14.5	4.2	0.1	2.2	3.7	9.8	0.6	0.2	0.0	1.9	2.0	5.4	0.5	0.4	0.5	0.2	2.3	4.2	2.3	9.3	0.4	0.6	0.0	22.6	5.6	17.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4	6.0	5.0	0.0	41.3	0.0	0.0	0.0	7.6	2.7	9.1	10.4	0.0	0.2	13.3	1.6	68.5	0.6	21.6	0.0	5.9	1.0	0.1	25.8	7.0	11.9	15.3	4.8	1.2	5.5	16.7	17.2	1.1	28.3	0.0	5.4	4.8	0.0	6.6	8.0	0.7	50.3	0.2	6.5	0.0	8.8	1.7	0.0	0.8	0.0	2.1	25.4
GPAT4	"AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7"	ENSG00000158669	"Glycerol-3-phosphate acyltransferase 4"	Q86UL3	8	41577187-41625001	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016471	Approved					NA	NA					"HPA016471: AB_1844649"	"unprognostic (3.05e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.08e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.98e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (1.73e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (5.65e-4)"	15.7	27.4	14.4	17.8	17.2	16.6	28.1	43.8	21.9	16.9	14.0	23.1	22.7	13.0	22.8	12.0	13.1	14.6	15.8	14.1	14.0	13.1	20.8	26.7	18.7	13.8	18.5	13.6	16.6	17.3	35.7	22.3	23.3	20.5	15.1	15.1	21.0	20.8	15.5	42.1	14.5	14.6	23.0	18.0	17.5	17.8	15.5	16.6	15.2	14.5	12.4	19.4	16.6	14.9	9.1	18.9	10.8	15.0	4.9	12.1	11.1	14.7	16.4	19.7	15.4	21.6	26.3	17.3	32.2	27.7	24.4	25.6	11.0	29.8	20.6	22.6	26.5	30.1	8.6	23.0	14.5	31.7	22.0	12.7	24.0	18.3	10.1	12.6	2.5	34.7	16.5	10.7	25.4	9.2	21.0	25.1	20.6	17.9	24.3	25.0	6.3	22.4	6.5	21.0	27.3	8.8	13.2	19.7	11.1	14.8	22.2	12.9	17.8	12.5	17.3	34.5	23.6	24.0	16.3	18.2	25.3	17.8	28.9	24.0	13.1	17.6	22.5	20.8	14.2	24.7	10.8	15.0	6.6	12.1	14.3	11.3	8.3	9.3	11.9	18.9	9.1	8.5	8.2	3.5	4.9	12.0	7.1	8.7	11.1	14.4	17.2	43.8	21.9	14.0	13.1	18.5	13.6	20.5	16.6	3.0	37.7	8.0	11.2	0.0	15.6	0.0	30.6	10.7	25.0	10.4	9.8	29.1	3.3	35.3	36.6	18.0	10.2	70.0	34.4	34.1	9.3	25.6	2.3	53.8	22.9	14.3	16.4	20.9	29.5	44.4	11.8	16.4	0.0	37.9	19.7	12.7	36.5	14.0	9.9	23.5	12.1	6.5	0.0	3.0	13.4	0.0	33.8	10.2	13.3	13.6
JMJD7-PLA2G4B		ENSG00000168970	"JMJD7-PLA2G4B readthrough"		15	41828095-41848155	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Club cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 5.6"									HPA005726	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA005726: AB_1852017"	"unprognostic (9.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.75e-3)"	6.6	2.8	4.7	5.2	4.9	6.8	4.5	21.4	5.3	6.0	4.3	6.1	5.5	2.7	4.9	3.5	8.7	6.5	3.8	3.9	4.9	2.2	2.9	3.0	6.7	3.8	5.3	3.6	5.5	5.8	2.7	4.3	1.9	5.5	4.3	2.5	5.3	9.0	7.7	4.9	12.0	4.4	4.2	3.7	3.6	4.0	2.6	5.2	1.9	4.6	5.9	7.0	6.4	6.3	0.7	1.3	0.0	1.5	0.7	4.0	1.0	0.8	0.5	1.2	4.2	1.1	3.1	1.9	0.9	2.2	1.4	2.0	2.0	0.1	0.4	1.8	1.1	0.1	4.3	0.4	3.4	0.3	0.0	0.4	0.6	0.9	0.6	4.7	0.0	2.5	1.6	2.3	0.5	1.1	0.0	0.5	1.7	0.0	0.6	0.4	0.7	0.9	0.1	0.1	1.1	0.2	0.6	0.0	1.5	1.1	5.6	1.5	1.8	3.8	0.0	0.5	0.2	0.9	4.4	0.7	0.7	0.6	4.8	1.7	1.2	0.4	0.0	2.2	0.6	0.4	0.0	1.1	0.0	4.0	1.5	1.9	0.7	0.4	0.6	1.3	0.1	0.7	0.0	0.0	0.7	1.0	0.0	0.1	1.0	4.7	4.9	21.4	5.3	4.9	2.2	5.3	3.6	5.5	5.2	8.9	4.5	0.0	0.1	0.1	0.6	0.4	0.0	1.4	4.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.8	0.0	0.4	0.1	0.2	0.1	1.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	11.0	14.6	7.9	13.3	1.8	4.2	11.3	8.0	8.0	8.5	7.2	14.7	13.0	7.1	7.4	12.4	10.6	12.5	26.1	10.8	8.5	9.0	8.9	13.1	9.2	14.1	8.4	18.5	10.0	3.2	8.5	9.0	12.6	5.6	5.9	4.1	12.0	6.8	6.5	8.6	10.5	10.9	8.6	9.0	8.4	10.3	15.8	14.5	6.8	16.2	9.2	14.2	17.9	11.9	10.3	5.7	8.6	6.4	6.7	15.5	12.9	8.3	12.5	4.9	10.3	16.0	15.8	13.6	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2	8.9	5.8	4.5	4.6	6.4	12.5	15.1	22.9	13.4	7.9	14.0	25.5	4.3	0.0	7.2	3.1	6.7	11.5	0.0	14.3	4.3	5.5	7.7	3.5	19.0	4.9	14.3	12.6	11.1	5.4	1.2	5.2	2.7	5.0	0.0	15.3	7.3	10.3	7.0	8.5	12.2	16.7	6.5	16.2	8.9	20.5	5.8	1.6	8.7	14.3	4.4
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1310.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.5	6.6	5.5	12.3	25.5	28.4	2.8	7.8	13.4	5.0	8.7	2.4	5.5	2.7	1.0	6.6	14.8	6.0	6.2	17.0	4.6	11.4	3.4	6.8	3.7	3.5	9.0	4.7	32.1	25.6	7.7	20.8	7.9	14.7	9.7	6.7	9.4	24.7	3.7	2.1	4.4	4.1	5.7	1.8	6.7	6.1	10.1	17.3	12.7	3.6	15.3	12.1	2.8	6.8	17.5	5.5	1.7	2.6	6.8	8.0	7.2	5.1	6.7	38.8	30.0	5.2	11.3	8.4	5.9	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2	20.8	49.1	22.9	38.9	16.9	40.6	49.5	25.5	61.6	63.7	10.4	80.5	7.3	6.6	18.7	314.7	24.6	9.7	0.0	24.2	5.3	24.6	29.2	33.6	21.9	8.1	46.1	34.7	15.4	15.7	1310.7	110.1	27.2	16.9	7.2	23.9	16.4	25.5	11.6	169.0	3.4	47.2	32.3	20.6	18.4	17.8	10.5	10.3	57.5	13.6	26.8
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell type enhanced"	"Detected in all"	5	"Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	12.0	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	18.6	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.2	17.2	2.5	11.8	10.3	17.3	14.8	8.8	8.3	1.9	16.7	3.7	9.1	6.3	3.4	7.4	9.6	16.1	9.2	13.4	9.5	11.1	9.0	6.2	11.2	5.3	3.8	6.4	0.0	10.1	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6	62.5	38.2	16.9	8.2	4.9	31.9	10.4	140.1	21.4	35.2	36.6	13.7	17.4	14.9	9.7	2.1	17.5	52.0	46.7	16.6	9.6	15.9	14.5	11.6	111.5	19.6	109.7	14.3	20.3	21.0	6.9	21.0	19.9	8.5	24.4	30.3	16.0	18.6	10.5	29.4	40.8	14.8	6.5	9.9	28.8	59.6	1.8	41.4	39.9	11.9	3.4
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 49.9;Late spermatids: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.9	6.8	0.4	4.1	11.2	17.5	5.3	4.3	6.0	5.3	7.2	12.7	6.2	0.3	5.4	9.4	5.6	17.7	2.1	11.2	3.3	0.1	4.0	0.3	9.6	6.4	1.8	0.0	4.8	12.6	14.3	8.9	3.5	6.2	1.3	0.1	1.8	0.2	6.6	14.9	0.0	0.1	0.6	4.3	7.1	0.0	0.1	0.5	18.4	8.8	0.5	0.1	5.7	7.4	3.6	3.5	8.6	3.5	0.4	0.3	1.7	5.9	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5	6.0	10.5	0.8	8.2	12.8	0.0	0.6	10.2	1.4	4.5	10.4	0.0	2.3	5.0	7.4	10.4	2.1	49.9	0.0	3.3	2.2	7.7	3.5	1.1	33.7	2.7	0.0	14.3	4.3	1.3	82.8	2.8	1.5	10.1	0.0	16.6	7.5	5.5	21.6	2.5	5.9	0.3	32.3	6.4	0.9	2.1	11.0	2.2	1.3	16.2	3.9
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20102145-20212399	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 9.7;Melanocytes: 8.5;Paneth cells: 8.6;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 30.3;HEL: 24.9;T-47d: 22.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	9.9	3.3	1.4	16.5	2.1	6.2	16.5	1.5	1.8	22.5	17.3	6.4	7.1	9.7	18.8	9.9	9.6	18.1	18.8	8.4	1.7	1.7	4.4	4.0	14.0	7.6	6.5	0.7	10.5	4.4	4.7	2.7	3.2	6.2	9.3	15.4	7.2	6.5	9.4	2.2	4.3	21.1	17.2	10.0	4.6	10.6	2.6	3.2	3.9	6.6	6.5	11.1	10.4	12.8	0.3	2.8	6.4	6.8	0.5	4.1	0.9	3.3	3.5	6.6	4.5	0.7	2.2	0.3	5.3	1.5	3.7	4.1	1.9	12.9	0.0	11.1	5.1	2.7	30.3	6.4	2.7	5.2	8.3	3.1	24.9	5.7	0.0	4.1	7.9	8.7	0.9	2.4	1.6	6.7	1.8	2.0	5.2	4.0	4.7	0.8	3.0	4.4	4.7	1.4	2.8	1.8	1.6	7.6	17.5	3.7	6.6	0.2	4.1	1.1	5.3	5.7	12.2	22.9	2.7	1.9	4.4	3.0	2.5	2.2	6.9	15.4	0.0	0.3	5.5	5.3	6.4	4.4	6.0	0.7	4.7	4.1	0.2	1.2	1.7	2.6	0.3	0.3	0.3	5.7	0.5	6.8	2.8	1.3	0.9	1.4	2.1	1.5	1.8	1.7	1.7	6.5	0.7	6.2	3.2	3.0	0.3	0.0	0.6	9.7	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.7	1.9	0.0	0.2	3.6	0.0	1.0	0.1	0.8	0.6	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.3	2.1	8.5	0.0	0.9	2.0	1.3	8.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	13.6	0.2	0.0	2.0	1.3
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 133.5;Muller glia cells: 95.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.4	2.6	7.9	3.4	3.6	8.0	4.6	4.1	1.5	5.3	3.5	0.7	13.5	2.4	4.9	9.7	4.2	6.5	7.0	8.2	8.0	7.5	12.1	10.1	3.7	0.0	4.4	0.0	3.2	5.8	4.9	5.0	3.5	11.7	2.8	3.5	8.6	1.9	4.6	2.2	3.0	0.2	3.1	3.8	10.0	4.5	12.5	0.1	7.8	1.2	4.7	14.5	4.2	25.5	4.0	4.1	4.8	2.9	1.5	9.4	5.0	7.2	11.6	0.7	0.2	2.7	14.7	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8	17.9	10.1	4.5	2.9	3.0	18.3	10.6	5.1	16.0	19.4	38.4	7.9	2.5	5.0	4.5	7.3	8.8	10.3	46.7	1.4	1.3	9.8	21.0	8.1	0.0	1.7	133.5	36.0	4.3	2.1	7.8	4.9	4.3	13.5	44.1	49.8	95.3	52.2	20.4	7.1	8.4	7.2	6.5	12.0	10.7	23.7	4.4	1.6	2.1	11.9	29.8
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672545-14694669	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.4;stomach 1: 13.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 54.8;Exocrine glandular cells: 106.2;Extravillous trophoblasts: 45.9;Mucus-secreting cells: 110.3;Paneth cells: 80.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 4.2;OE19: 4.6;SK-BR-3: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	9.4			2.4	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0		0.0	4.2	0.0	0.0	0.0		0.2	7.2		0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.0	2.1			0.0		0.0	2.8	0.0	0.9	0.5	2.0	0.5	0.1	0.4	0.1	0.1	0.9	0.1	0.1	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.6	4.2	0.3	0.4	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.7	0.0	1.9	0.3	0.2	0.4	4.6	0.1	0.8	0.3	0.2	0.0	0.3	0.6	0.5	1.0	2.6	0.3	0.3	0.4	0.4	0.8	0.0	0.3	0.1	0.0	0.7	2.1	0.7	0.6	0.1	0.1	0.1	0.5	0.5	0.3	0.4	0.3	0.1	0.2	0.4	0.5	0.9	0.3	0.3	2.0	0.1	0.3	0.3	0.1	0.1											32.8	17.2	0.0	0.7	0.0	0.0	0.0	10.2	32.1	9.1	1.8	0.0	0.4	0.0	0.3	0.3	0.0	54.8	0.0	106.2	45.9	0.0	1.9	0.0	0.0	0.8	0.0	12.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	110.3	0.0	15.5	80.4	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.5	0.0	23.8	12.6
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730077	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA					"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	9.8	9.9	13.1	4.4	16.2	5.6	12.9	14.5	14.3	9.6	12.2	13.4	7.3	11.9	8.9	8.2	12.6	9.2	9.2	21.0	13.0	11.4	15.3	20.6	7.8	4.9	16.8	11.7	11.9	38.8	22.8	19.0	10.4	12.7	16.4	12.0	10.7	12.1	8.3	21.1	9.8	16.3	8.1	20.3	5.5	10.0	5.7	12.4	4.9	19.0	9.2	6.2	7.5	7.7	4.9	8.7	3.6	4.6	4.9	10.2	13.8	9.6	3.6	2.8	4.2	9.0	9.0	5.5	8.9	7.1	5.0	5.3	8.9	17.0	13.8	6.7	6.5	8.4	5.4	8.6	11.5	7.7	5.1	13.4	4.9	10.4	5.3	8.9	10.6	3.5	9.1	13.4	5.1	12.6	9.1	5.0	13.0	27.0	6.4	8.5	17.0	8.6	4.8	5.0	22.0	14.0	5.2	8.5	10.9	9.4	14.3	18.1	6.0	7.8	20.7	6.7	7.6	12.4	2.3	5.9	7.3	6.1	7.5	6.1	10.9	19.6	10.2	8.2	6.2	9.1	3.6	4.6	2.7	7.2	2.9	6.6	4.2	9.0	6.9	8.7	4.9	10.2	9.2	2.2	4.9	4.4	7.6	8.7	13.8	13.1	16.2	14.5	14.3	13.0	11.4	16.8	11.7	12.7	12.4	23.8	17.9	15.2	28.9	32.5	46.8	53.4	30.6	10.7	13.6	21.0	47.1	33.9	23.2	12.4	18.0	12.7	27.4	23.3	22.2	44.9	23.9	62.2	13.9	86.9	17.1	25.4	103.4	18.4	19.4	7.1	30.8	8.9	28.7	1.8	52.7	39.7	13.5	35.1	32.5	14.6	39.5	19.4	19.1	55.2	41.1	37.3	28.8	13.8	59.3	35.7
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72935170-72954778	"Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 47.8;liver: 42.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 47.8"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 12.1;Hep G2: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA					"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	25.6	0.0	0.0	15.4	0.1	0.3	0.1	0.1	0.0	3.5	0.1	0.1	8.0	42.8	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	47.8	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	20.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	1.8	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.9	0.0	9.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PLA2G16	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754."	ENSG00000176485	"Phospholipase A2 group XVI"	P53816	11	63573195-63616883	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.6"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 759.2;Proximal tubular cells: 471.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 52.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.4;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	113.6	15.2	32.0	4.4	39.4	1.6	33.9	4.8	30.2	6.1	7.2	46.6	6.1	4.0	5.0	11.5	5.9	13.9	12.9	39.0	37.6	25.2	24.7	28.9	13.5	4.5	58.4	22.2	30.9	13.2	15.1	8.1	16.2	30.5	5.9	3.7	8.8	10.1	13.2	37.8	2.4	7.5	8.0	70.4	6.4	10.2	17.8	48.9	0.1	17.1	11.1	2.3	8.0	4.7	2.1	52.4	0.4	6.2	5.3	16.0	6.4	20.6	32.7	0.9	0.0	37.1	6.4	6.0	0.7	6.6	5.5	2.7	7.4	59.7	0.0	13.8	1.6	18.0	1.0	30.9	1.6	4.2	25.5	1.2	0.3	7.8	1.2	22.1	0.0	0.3	3.8	0.1	13.6	0.5	22.0	8.6	0.0	0.3	2.3	5.8	3.6	0.0	0.1	2.6	13.0	10.6	0.0	0.0	2.0	17.3	2.9	0.4	2.4	4.4	12.5	6.8	14.0	27.1	1.0	12.6	2.4	0.1	8.3	1.8	9.8	6.4	0.0	9.9	0.0	0.2	0.0	6.2	0.0	16.0	2.4	8.8	2.1	3.7	11.6	1.7	0.3	1.2	9.4	0.4	5.3	0.1	52.4	2.4	6.4	32.0	39.4	4.8	21.9	37.6	25.2	58.4	22.2	30.5	48.9	95.3	77.4	17.6	17.3	10.3	10.6	128.7	96.8	113.8	45.5	109.9	3.9	112.1	96.2	54.1	56.9	116.5	22.2	0.0	99.5	300.4	35.3	29.0	56.6	210.7	56.9	38.1	3.4	165.7	48.0	16.0	28.7	51.4	25.3	759.2	4.5	120.3	123.3	14.4	20.5	471.4	17.2	12.9	42.8	135.2	4.9	8.2	243.0	69.8	1.7	59.6
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322111-120327789	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	933	"pancreas: 2360.6"	"Cell type enriched"	"Detected in many"	10	"Exocrine glandular cells: 17927.2"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	19	"NK-cells: 1.3;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 6.4;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	1.1	2360.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	2.5	0.9	0.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.3	1.6	0.0	0.0	0.3	0.0	0.1	0.6	0.0	1.0	0.2	4.7	0.6	0.6	0.0	1.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.3	0.0	0.0	2.5	0.9	0.0	1.3	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.9	65.5	0.0	0.1	0.0	0.0	0.3	0.0	1.4	1.2	0.0	0.0	0.0	1.7	16.1	7.5	0.0	0.7	0.0	17927.2	0.0	0.0	0.2	0.0	1.6	0.0	0.0	1.2	0.0	0.0	27.8	2.8	0.3	0.0	76.7	1.0	0.0	1839.8	1.1	3.2	2.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	1.2	0.0
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 366.3;Exocrine glandular cells: 945.9;Glandular cells: 937.5;Paneth cells: 354.3;Undifferentiated cells: 591.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Hep G2: 23.4;OE19: 64.1;RT4: 21.5"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	290000			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	25.2	1.0	0.0	13.1	0.0	0.6	14.0	0.0	0.6	1.4	63.9	0.0	0.1	35.0	0.7	22.7	31.5	11.7	2.4	105.4	0.0	0.0	1.6	377.9	3.0	6.5	0.0	0.0	35.6	2.4	0.6	0.5	15.5	0.0	27.1	68.2	6.1	9.5	1.0	30.6	5.0	99.0	39.7	0.0	0.6	4.0	9.8	0.0	0.0	16.0	8.9	19.3	39.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.6	0.0	21.5	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.1	6.7	10.0	12.4	0.0	7.2	5.1	2.7	6.8	0.0	0.0	2.8	1.7	0.0	3.0	8.4	366.3	0.0	945.9	3.3	308.9	937.5	4.6	51.6	8.2	0.0	59.8	35.0	6.0	7.5	158.5	4.9	13.5	0.0	270.5	0.0	3.6	354.3	1.1	0.0	0.0	0.0	11.3	0.5	0.1	14.6	5.7	8.4	591.0	9.1
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.6;Late spermatids: 7.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HL-60: 4.5;NB-4: 1.4;SK-BR-3: 1.3;U-698: 5.0;U-937: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.3	0.1	0.3	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	5.0	0.4	4.8	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	10	"Kupffer cells: 2.2;Melanocytes: 5.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	13.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.3	0.2	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Innate immunity, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.5"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"RT4: 56.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favorable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.7
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"	NA	NA					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1	0.0	2.2	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.6	0.0	0.0	0.0	0.4
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 19.1;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.0;OE19: 33.2;RPMI-8226: 28.5;U-2197: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		78000	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	15.8	0.0	0.0	9.9	4.0	0.0	0.6	6.1	0.7	1.3	0.1	6.2	0.0	0.0	0.0	2.8	1.1	9.9	2.9	0.3	4.8	0.2	2.9	23.0	0.0	6.1	4.3	1.5	2.2	2.0	7.9	1.6	1.0	6.6	1.3	6.4	2.3	0.0	0.0	0.0	0.0	0.8	33.2	2.1	0.0	0.0	28.5	0.0	2.1	0.0	0.0	2.3	0.8	2.8	0.3	0.3	5.8	1.3	5.9	0.8	27.0	1.2	0.9	0.0	0.0	2.1	12.8	8.3	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3	0.0	0.6	0.0	2.8	19.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	1.6	0.7	6.0	1.3	0.0	0.0	0.0	4.3	1.7	10.4	0.0	5.5	0.0	1.2	1.3	8.8	0.6	9.8	6.0	5.0	1.0	1.7	0.0	1.1	2.8	13.8	0.1	0.2	0.0	3.4	0.5	0.1	7.9	0.0	0.0	2.9	10.5
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.9;Club cells: 2.3;Rod photoreceptor cells: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 10.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 11.0;T-47d: 5.9"															NA	NA						"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	1.8	1.2	1.8	1.8	2.2	3.4	3.6	10.8	2.1	6.1	1.8	1.8	1.8	1.9	2.7	2.3	19.3	2.0	1.9	1.8	1.8	2.5	2.5	2.6	2.2	3.3	1.8	1.8	4.2	3.5	1.4	3.2	1.8	1.8	4.8	1.1	1.8	7.0	2.7	1.8	32.8	2.4	1.8	1.8	3.0	1.8	1.8	1.8	2.2	4.8	56.0	36.0	2.0	5.9	3.0	0.5	0.2	0.8	3.9	1.5	0.1	1.3	0.7	0.0	0.0	0.1	0.0	3.7	0.4	1.2	1.3	0.1	0.3	0.7	0.3	0.1	0.7	0.1	4.4	1.5	0.5	0.3	0.0	2.5	1.1	1.4	3.4	1.7	0.2	1.4	0.9	4.9	0.2	1.3	0.1	0.6	1.9	1.7	0.2	0.4	2.1	1.0	4.1	1.0	5.5	1.2	0.0	1.2	0.9	1.0	11.0	0.2	1.1	0.0	2.0	1.0	0.9	5.9	1.8	0.0	0.0	1.0	1.0	0.1	3.4	0.0	0.9	0.3	5.0	0.0	0.0	0.8	0.0	1.5	0.5	0.9	0.1	0.4	0.8	0.5	3.0	0.9	0.8	0.2	3.9	0.2	0.5	1.2	0.1	1.8	2.2	10.8	2.1	1.8	2.5	1.8	1.8	1.8	1.8	0.0	1.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;skeletal muscle: 45.0"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 54.2;Cone photoreceptor cells: 62.8;Muller glia cells: 53.7;Rod photoreceptor cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 8.2;HHSteC: 13.4;TIME: 18.6"	"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	4.0	11.7	8.9	4.2	23.2	0.4	3.0	12.9	14.5	3.4	3.5	23.4	2.0	5.1	6.8	5.2	3.6	4.3	4.6	18.5	10.0	10.0	4.4	3.8	5.9	7.2	31.8	8.5	2.0	4.1	14.8	4.6	4.1	16.9	5.7	2.9	5.4	3.1	6.7	45.0	4.9	6.7	8.1	18.6	8.1	2.4	2.4	17.1	0.7	3.3	7.5	4.3	4.9	2.1	5.4	2.0	0.0	7.9	1.5	0.8	2.0	0.7	1.1	0.0	0.3	5.2	3.0	0.1	1.3	8.2	1.2	3.5	0.0	2.1	0.0	1.8	3.2	2.6	0.2	0.0	0.2	2.0	0.8	0.1	0.0	0.3	1.2	13.4	0.0	1.8	0.6	0.3	0.5	5.4	2.5	5.1	0.0	0.0	7.4	2.0	2.0	0.0	0.1	0.1	0.9	0.1	0.1	1.8	0.7	2.5	0.4	0.8	0.1	1.5	2.6	6.3	4.2	0.7	1.8	18.6	2.3	0.7	2.5	0.9	0.5	1.4	0.2	1.6	0.0	4.4	0.0	3.2	0.0	0.2	7.9	0.6	5.4	0.8	0.0	2.0	1.6	0.0	0.0	0.0	1.5	2.0	1.4	0.2	2.0	8.9	23.2	12.9	14.5	10.0	10.0	31.8	8.5	16.9	17.1	3.0	1.7	0.5	0.8	2.5	54.2	30.9	10.2	0.0	0.0	0.0	62.8	0.1	1.7	7.7	0.2	16.9	1.6	0.0	2.5	0.2	3.8	1.7	0.0	1.0	5.0	31.8	0.0	3.1	0.3	0.0	0.6	2.8	6.8	4.6	1.5	53.7	4.1	0.3	7.4	3.4	133.4	12.9	11.8	0.3	0.5	2.6	0.1	0.0	0.0	0.1
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 2.0;Glandular cells: 2.2;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	19.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	3.0	0.0	0.0	0.0	0.3
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 19.9"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 2: 8.0;Basal keratinocytes: 16.1;Suprabasal keratinocytes: 39.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;HaCaT: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041105	Enhanced					NA	NA					"HPA041105: AB_2677300"	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0			0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	8.0	0.0	0.2	16.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	39.3	0.0	0.0	0.0	0.5
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 14.1;RT4: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	14.1	0.1	0.0	0.0	0.1	0.0	10.6	0.6	0.1	0.0	1.1	0.0	0.1	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	54.9	0.0	3.3	4.8	0.0	3.2	0.0	0.0	0.0	5.2	0.0	1.5	3.3	0.2	0.0	0.0	12.0	0.0	1.2	0.7	0.2	2.7	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	4.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	1.0	0.0	4.3	1.6
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"	NA	NA					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3	0.0	0.3	0.0	0.0	0.3	9.3	79.9	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	2.1	1.5	0.0	0.0	0.2	0.0	0.0	8.6	0.8	3.6	75.4	0.0	0.0	0.0	0.0	25.1	0.0	0.0	68.9	0.0	27.8	258.7	2.4	0.5	0.6	0.4	0.2	0.0	0.0	0.0
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38205690	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 31.8;HMC-1: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	16.2	17.7	15.6	8.5	20.5	13.1	15.6	15.9	26.3	14.8	7.9	36.9	18.5	9.8	16.3	20.5	8.7	21.6	25.3	6.3	19.7	7.2	18.1	8.6	9.0	12.4	19.3	16.7	21.3	12.8	24.2	12.7	6.8	19.5	17.6	6.3	12.9	20.2	17.4	7.4	18.1	8.7	7.8	14.9	12.1	9.5	30.0	23.2	16.3	45.7	4.1	11.3	12.1	11.2	1.8	5.4	4.1	0.9	8.8	5.7	1.9	0.7	2.8	3.0	7.8	10.1	5.0	8.2	0.9	1.0	0.8	1.1	3.1	1.8	5.9	6.6	2.3	1.3	3.6	3.5	1.9	1.0	9.0	13.2	31.8	3.9	3.6	2.8	3.5	20.3	16.3	4.3	2.8	4.5	8.2	1.0	13.0	5.2	10.7	1.5	4.6	6.6	2.1	2.6	2.1	1.8	4.9	1.2	4.5	2.9	7.0	5.8	2.4	1.3	3.1	7.2	4.5	3.3	2.5	1.3	2.6	4.5	1.1	0.6	17.6	3.1	3.1	3.7	4.1	1.6	4.1	0.9	0.4	3.8	0.3	1.9	1.8	3.1	5.7	1.5	1.5	1.4	3.9	3.3	8.8	0.6	5.4	3.7	1.9	15.6	20.5	15.9	26.3	19.7	7.2	19.3	16.7	19.5	23.2	3.0	2.4	4.4	3.6	2.7	9.4	1.5	2.5	5.3	5.7	12.2	3.9	2.5	0.0	1.4	16.1	1.9	11.0	0.0	0.9	2.4	2.1	4.2	0.0	3.4	1.4	14.3	10.9	3.7	1.5	13.7	5.5	1.0	1.7	3.6	6.9	4.5	1.4	11.5	3.5	0.8	7.0	6.5	1.7	23.8	7.5	3.0	4.1	6.9	6.9	1.3
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28643788	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 66.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 22.5;Extravillous trophoblasts: 20.1;granulocytes: 5.7;Hofbauer cells: 10.2;Kupffer cells: 12.3;Late spermatids: 11.8;Macrophages: 8.7;Syncytiotrophoblasts: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.8;OE19: 12.0;RT4: 4.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	0.9	3.3	0.7	1.0	2.1	2.9	1.0	0.6	0.7	0.9	0.8	0.6	0.6	0.2	0.8	1.7	1.3	0.7	0.9	1.4	0.6	0.9	0.8	0.6	0.7	0.6	0.8	0.6	0.6	0.6	0.0	0.7	1.3	0.7	1.0	1.1	0.7	0.6	0.9	0.9	5.2	66.7	1.7	0.8	2.8	0.5	1.2	0.6	0.6	1.2	0.9	0.6	0.9	0.6	0.0	6.4	9.9	5.2	0.0	0.1	1.1	0.6	0.1	3.8	0.1	0.8	0.6	5.8	0.1	1.5	0.4	0.3	3.8	0.4	0.4	0.4	0.6	1.7	0.8	0.0	3.1	0.3	0.2	0.0	0.3	0.6	0.7	1.3	0.7	0.3	0.6	1.8	0.6	1.0	0.7	1.0	0.0	0.0	0.1	1.1	0.0	0.0	0.5	0.1	12.0	0.8	0.0	0.6	0.0	1.7	4.3	1.7	0.3	0.1	0.2	0.3	0.3	0.0	2.0	0.4	0.4	1.1	0.2	0.2	0.8	0.2	0.0	1.3	2.9	0.1	0.0	3.1	3.3	0.0	4.9	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	9.9	0.0	5.2	0.3	0.1	1.1	0.7	2.1	0.6	0.7	0.6	0.9	0.8	0.6	0.7	0.6	0.0	1.1	0.0	0.8	0.3	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.4	1.7	0.9	22.5	0.3	1.7	0.0	0.8	20.1	0.5	0.3	5.7	0.0	10.2	0.0	1.2	0.6	12.3	11.8	1.1	8.7	0.0	0.0	1.1	0.6	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.2	0.4	6.9	0.5	0.3	1.4
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55535050	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 254.8;Leydig cells: 203.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	56.3	26.7	12.5	14.8	14.6	0.6	57.9	10.6	18.5	34.5	30.9	26.1	18.0	17.3	36.8	26.0	18.4	20.4	61.0	33.7	13.4	10.8	34.5	42.0	15.9	17.3	20.8	10.1	16.5	17.6	16.9	10.1	22.4	21.4	82.0	24.7	29.8	9.8	24.0	18.4	16.6	25.4	39.6	28.2	10.2	21.7	18.1	14.5	4.4	32.7	9.6	10.0	43.1	18.1	5.4	13.6	3.3	0.7	2.7	9.5	1.6	2.0	4.9	1.4	2.9	93.3	10.9	2.0	4.4	12.4	2.4	5.8	3.4	3.6	2.0	4.2	28.4	6.7	1.3	5.1	2.5	2.8	1.3	4.0	0.2	2.1	4.2	14.7	0.5	48.9	35.8	5.3	3.6	2.2	4.9	4.0	1.9	0.0	5.7	4.9	1.2	1.3	1.0	3.3	0.2	4.0	0.4	2.4	0.1	9.3	15.9	1.8	1.2	4.4	0.9	2.6	6.4	3.2	0.3	4.9	0.8	1.5	3.7	3.1	3.5	1.4	2.4	3.3	0.2	4.0	0.0	0.4	3.3	1.5	0.4	1.6	5.4	5.2	3.2	1.9	3.4	9.5	7.5	0.3	2.7	0.7	13.6	2.2	1.6	12.5	14.6	10.6	18.5	13.4	10.8	20.8	10.1	21.4	14.5	6.0	10.3	3.9	48.9	0.0	5.2	0.0	15.3	4.0	10.3	27.9	2.0	2.2	5.0	22.3	30.3	45.0	26.9	0.0	24.7	9.6	32.8	109.6	25.6	50.5	11.0	1.6	1.2	254.8	14.9	19.1	203.1	3.6	0.0	7.2	23.2	14.3	28.1	29.4	83.1	24.5	4.8	58.2	0.0	47.0	18.1	0.0	4.1	4.3	14.9	41.0
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291504	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4;MAIT T-cell: 9.4"	"Lineage enriched"	"Detected in single"	52	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"A549: 34.1;CAPAN-2: 37.1;OE19: 63.6"	"Low region specificity"	"Detected in many"							HPA055540	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055540: AB_2682839"	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	1.4	4.7	8.3	5.3	20.9	0.2	17.5	2.0	11.1	30.4	18.2	28.1	13.4	27.5	7.7	4.1	9.1	38.1	31.2	1.5	13.6	7.1	4.7	1.1	3.7	0.8	37.1	6.5	2.4	19.8	0.6	4.1	1.8	16.6	10.7	15.3	6.7	45.8	19.0	0.3	19.0	21.9	3.3	26.0	1.4	22.2	2.2	25.8	0.7	2.2	5.9	5.0	12.1	5.7	0.0	0.1	0.1	0.0	0.0	9.4	0.3	20.0	34.1	0.5	0.0	0.0	0.1	0.0	2.0	0.0	6.3	4.9	9.8	37.1	0.0	21.9	2.9	0.0	11.1	0.0	4.4	2.9	0.2	0.6	0.0	13.7	0.0	7.6	0.0	1.3	1.3	1.9	3.2	4.3	13.9	1.0	0.0	0.1	0.0	0.0	22.8	0.1	0.0	15.2	63.6	0.0	0.0	0.0	0.5	16.0	3.2	4.3	10.2	5.6	9.4	14.7	1.5	12.3	0.6	1.1	13.9	9.2	0.1	14.8	0.1	23.3	16.5	3.9	0.0	11.4	0.0	0.0	0.0	4.4	0.0	9.4	0.0	2.0	2.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	8.3	20.9	2.0	11.1	13.6	7.1	37.1	6.5	16.6	25.8	6.0	6.9	0.0	113.1	0.0	17.7	0.0	188.5	167.3	64.8	21.0	9.8	0.2	3.3	295.2	0.2	3.3	108.1	0.0	125.6	5.1	0.0	71.8	1.1	0.4	0.9	15.9	8.2	0.0	1.3	1.4	0.0	1.3	0.0	4.6	39.9	12.1	100.4	109.1	0.0	1.0	190.0	0.0	0.0	0.3	28.1	0.0	0.7	0.0	113.0	167.4
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120456954-120589855	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 26.5;kidney: 12.6"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 62.8;U-251 MG: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.6	1.7	11.4	1.2	13.6	4.9	3.1	11.6	18.2	3.4	1.2	12.1	1.0	0.7	1.7	2.7	0.9	1.2	11.3	0.7	15.9	17.4	12.6	2.8	0.5	0.6	15.5	6.0	0.6	0.6	0.4	0.5	0.6	26.5	3.0	0.8	0.0	2.0	6.1	0.4	1.7	0.8	1.5	19.1	0.5	1.2	11.1	12.5	0.0	1.5	0.0	0.5	0.8	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.8	1.7	1.0	0.0	1.0	0.0	0.0	8.0	6.3	0.1	0.7	0.1	0.9	1.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	62.8	6.5	0.0	0.7	1.6	0.7	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	3.3	0.0	0.6	0.1	0.5	0.0	0.5	3.5	1.4	0.0	9.0	7.2	4.0	0.3	34.8	0.0	0.0	0.0	6.6	0.0	1.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.6	11.6	10.0	15.9	17.4	15.5	6.0	26.5	12.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	12.7	0.0	0.0	3.5	0.0	0.0	6.6	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	2.5	0.0	7.9	17.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.4	7.6	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.8"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"memory B-cell: 37.2;naive B-cell: 65.4"	"Lineage enriched"	"Detected in all"	5	"B-cells: 65.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	5.5	9.3	6.9	11.9	7.9	4.8	8.8	7.5	6.7	11.2	11.5	3.9	33.9	14.4	5.7	30.9	6.6	10.2	21.0	4.6	6.1	6.1	9.6	20.3	7.5	12.0	4.5	5.1	8.4	77.8	4.2	29.9	8.3	6.7	27.9	12.8	16.2	52.0	36.5	2.3	4.7	18.4	5.2	3.5	12.8	16.1	4.6	4.4	3.8	11.9	5.0	14.8	8.0	6.7	65.4	5.3	13.3	3.6	4.3	5.0	3.7	5.5	11.1	6.6	13.5	13.0	12.7	9.1	15.8	19.9	8.1	10.6	5.1	8.5	0.4	13.5	16.3	11.7	6.2	5.4	11.5	6.9	3.5	3.5	9.8	4.7	14.8	22.1	2.8	11.8	9.9	12.0	11.2	14.8	14.3	13.1	13.1	0.4	25.5	9.8	11.4	6.3	4.7	10.0	22.5	3.8	6.9	4.9	51.3	20.2	7.2	5.2	8.0	6.5	10.1	9.2	6.1	21.6	5.5	7.8	5.7	5.0	9.6	4.1	15.8	10.4	1.6	15.8	7.5	9.8	13.3	2.7	4.5	3.0	2.7	5.0	37.2	3.9	3.8	2.5	65.4	2.0	1.9	1.6	4.3	3.6	5.3	3.4	3.7	6.9	7.9	7.5	6.7	6.1	6.1	4.5	5.1	6.7	4.4	8.9	44.0	74.7	61.1	0.0	5.3	0.0	38.2	101.7	39.8	71.5	15.7	39.2	36.5	59.1	22.7	13.5	17.2	0.0	78.1	37.8	35.3	138.3	29.1	20.7	32.8	58.8	43.3	16.5	9.1	6.2	16.4	24.8	0.0	10.0	73.6	37.6	56.5	36.8	8.9	20.3	3.5	12.9	0.0	24.7	4.3	0.0	73.7	17.0	51.4	46.1
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 32.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 32.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	12.0	17.1	32.5	10.5	39.9	14.1	6.6	17.7	51.2	14.0	11.1	10.8	5.1	6.0	12.7	8.4	8.4	9.7	13.7	10.4	37.0	22.3	5.5	18.0	10.0	5.4	11.8	17.9	15.2	12.4	11.7	22.7	11.5	12.3	18.5	5.1	11.8	13.1	15.1	23.1	16.2	5.7	16.8	10.5	10.6	9.3	7.6	9.4	0.5	7.7	4.4	3.3	9.8	8.1	0.0	2.9	32.3	7.2	0.0	0.3	2.3	8.8	5.5	3.0	12.6	12.8	12.3	0.8	15.8	14.7	9.8	10.1	1.0	1.6	1.7	9.4	20.1	2.0	1.6	1.7	4.7	5.3	4.6	3.2	0.5	3.8	1.0	6.7	0.5	18.0	11.0	8.6	8.4	1.6	14.2	6.6	2.8	8.5	14.1	8.2	13.1	0.2	2.4	3.3	3.0	30.7	0.2	0.4	4.8	4.6	4.2	3.3	10.9	6.6	5.7	3.3	1.0	8.2	11.3	7.6	22.2	4.7	37.5	8.3	8.8	5.4	0.6	21.6	8.1	8.7	0.8	7.2	3.7	0.3	6.7	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	32.3	0.0	4.4	0.1	0.3	2.3	32.5	39.9	17.7	51.2	37.0	22.3	11.8	17.9	12.3	9.4	6.0	8.8	0.5	5.5	0.0	5.1	0.0	7.6	2.7	2.3	3.5	11.8	0.5	1.7	6.2	11.0	6.9	0.0	0.0	7.6	2.1	2.1	16.2	2.3	6.7	4.0	7.9	16.4	8.0	9.7	8.2	13.3	3.9	0.0	0.0	2.5	15.3	7.5	0.0	15.6	1.3	6.3	6.5	0.0	1.8	4.9	0.0	2.4	0.0	0.8	4.1
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Cell type enhanced"	"Detected in single"	21	"Horizontal cells: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"NB-4: 24.1;THP-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	5.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.1	0.9	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.2	1.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.4	0.0	24.1	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	2.7	2.2	51.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.9	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 55.3"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 28.6;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	22	"monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 20.3;BJ hTERT+ SV40 Large T+ RasG12V: 7.9;fHDF/TERT166: 6.8;SH-SY5Y: 15.3;U-138 MG: 7.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	3.0	1.7	25.1	1.2	25.8	0.8	1.8	2.0	55.3	4.6	1.5	2.6	0.0	1.2	1.7	1.7	3.2	1.3	6.0	1.4	39.2	10.8	1.4	0.8	3.5	1.5	5.2	16.7	0.8	1.5	1.7	9.0	1.9	6.1	1.1	1.9	0.6	1.4	1.3	1.2	4.6	1.5	2.1	2.2	1.3	1.1	5.2	2.7	0.0	1.5	0.4	1.7	7.0	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	3.9	20.3	4.5	7.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	25.1	25.8	2.0	33.8	39.2	10.8	5.2	16.7	6.1	2.7	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	25.5	0.0	0.0	1.4	0.6	4.3	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0
SELENOI	"EPT1, KIAA1724, SELI, SEPI"	ENSG00000138018	"Selenoprotein I"	Q9C0D9	2	26308547-26395891	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 11.9;Collecting duct cells: 21.0;Ductal cells: 9.5;Pancreatic endocrine cells: 11.6;Syncytiotrophoblasts: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064125	Approved					NA	NA					"HPA064125: "	"unprognostic (6.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.00e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.42e-2)"	5.5	8.8	10.3	7.0	20.6	13.3	10.8	21.4	22.5	7.1	10.7	14.1	5.0	15.3	5.8	7.6	15.7	5.0	5.6	6.1	14.7	11.3	10.6	28.6	6.7	6.9	9.7	9.4	5.9	11.3	27.2	11.7	8.5	14.9	8.5	11.5	9.2	9.5	6.2	10.1	22.5	22.1	5.2	15.6	6.3	9.1	5.8	11.0	8.0	9.4	9.4	9.1	7.1	9.9	5.4	3.0	0.6	2.5	2.1	5.0	1.0	19.5	12.1	10.0	10.0	6.3	5.1	15.3	9.6	4.4	4.9	5.0	25.4	12.6	22.8	11.7	4.5	10.4	16.1	15.5	8.5	7.1	6.3	7.3	14.4	8.7	14.9	6.0	19.1	4.7	4.0	7.6	10.7	10.7	2.9	4.4	8.3	16.3	8.0	6.4	8.5	11.3	9.6	12.9	10.0	8.3	10.4	23.7	11.6	9.4	15.2	22.0	9.4	8.1	17.3	7.7	8.7	8.3	5.7	7.1	8.3	10.8	10.9	14.7	10.9	26.9	31.2	8.5	11.9	7.4	0.1	1.7	0.0	2.2	2.5	2.3	5.4	2.3	2.9	1.7	2.6	3.0	5.0	0.6	2.1	2.1	3.0	4.1	1.0	10.3	20.6	21.4	22.4	14.7	11.3	9.7	9.4	14.9	11.0	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.7	21.0	0.0	5.1	0.0	9.5	0.0	0.0	0.0	0.0	8.9	4.9	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	11.6	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0
